Markets
BSE See NSE See 49,580.73
848.18 (1.74%)

Vivimed Labs Ltd. Industry : (Pharmaceuticals)

Quick Glance

Listed on BSE and NSE
  • Market Cap 259Crores
  • Book Value 57
  • Face Value 2
  • Current Price 31.20
  • % Change -4.88
  • 52 week H/L 42/ 10
  • TTM P/E -2.14
  • Dividend Yield 0 %

Stock vs. Index

Vivimed Labs
Sensex

Historical Return

1 Yr (%) 2 Yr (%) 3 Yr (%) 4 Yr (%) 5 Yr (%)
182.35 55.22 -54.42 -72.81 -62.95

ROCE Vs RONW

ROCE
RONW

Price History

You can view historic prices (Open,High,Low,Close) of the company for the range of days

Shareholding Pattern


collapse Financial Performance collapse

Quarterly Results

(All figures In Rs. Cr.) Dec 18 Mar 19 Jun 19 Sep 19 Dec 19 Mar 20 Jun 20 Sep 20 Dec 20
Sales 51.72 74.60 59.11 99.62 62.77 55.10 53.53 59.40 62.44
Other Income 0.17 7.64 2.63 1.01 1.31 1.59 1.36 1.36 1.57
Operating Profit 15.75 17.29 12.63 9.49 10.18 -0.01 15.38 12.98 13.71
Interest 11.31 18.14 9.98 11.15 11.85 10.02 11.40 9.83 11.13
Depreciation 4.31 4.70 4.29 4.19 4.17 3.92 3.94 3.95 3.95
Taxation -0.77 -0.42 0.25 -1.21 0.00 -0.61 0.23 0.00 0.00
Net Profit / Loss 1.07 2.52 0.75 -3.64 -4.53 -11.74 1.17 0.55 0.20

Annual Results

(All figures In Rs. Cr.) Mar 12 Mar 13 Mar 14 Mar 15 Mar 16 Mar 17 Mar 18 Mar 19 Mar 20
Sales 383.32 426.50 433.54 431.58 320.38 569.84 261.39 251.81 276.61
Other Income 0.00 0.00 0.00 0.00 0.00 2.34 1.93 8.53 6.53
Operating Profit 84.43 97.03 101.21 107.15 86.19 259.48 76.87 67.26 32.29
Interest 22.53 28.44 44.34 62.34 56.06 53.55 51.80 52.40 43.00
Depreciation 10.55 17.21 18.06 20.56 18.79 26.83 18.14 18.26 16.57
Taxation 10.93 14.65 12.18 5.32 3.21 48.76 -1.02 -1.06 -1.57
Net Profit / Loss 40.41 36.74 26.63 18.94 8.13 132.68 9.87 6.19 -19.17

Compounded Sales & Net Profit Growth

Period Sales % Net Profit %
TTM -22.16% NA
1 Years 9.85% NA
2 Years 2.87% NA
3 Years -21.41% NA
4 Years -3.61% NA
5 Years -8.51% NA

Investor Returns

Type Ratio / % Date
Dividend
20.00
19 Sep 2018
Split
10:2
06 Apr 2016

Announcements

Date Title
May 10, 2021 Vivimed Labs gets DGHS nod to manufacture, market Favipiravir tablets in India
May 10, 2021 Vivimed Labs - Press Release
May 10, 2021 Vivimed Labs - Announcement under Regulation 30 (LODR)-Press Release / Media Release
May 10, 2021 Upper circuit stock: Vivimed Labs surges nearly 5 per cent on receiving nod to manufacture Favipiravir
Apr 30, 2021 These stocks doubled investors’ wealth in just a month

collapse Peer Review collapse

Peer Companies

Company CMP (Rs.) % Change Market Cap (Rs. Cr.) 52 Week H/L Book Value (Rs.) PE (x)
1 2 3 4 5 >
Sun Pharmaceutical Industries Ltd.
686.95
-0.60%
164,822.32
721.90 / 434.25
188.65
43.78
Divi's Laboratories Ltd.
4,043.20
0.53%
107,334.26
4,203.00 / 2,094.60
275.36
77.97
Dr. Reddy's Laboratories Ltd.
5,251.25
1.07%
87,328.93
5,514.65 / 3,613.45
1,060.83
44.75
Cipla Ltd.
881.05
-2.55%
71,053.78
966.00 / 570.45
194.80
29.55
Cadila Healthcare Ltd.
611.60
-0.89%
62,612.10
673.70 / 321.80
101.35
53.21
Aurobindo Pharma Ltd.
1,001.00
-0.56%
58,652.45
1,063.75 / 655.00
286.90
20.72
Lupin Ltd.
1,188.95
0.86%
53,946.04
1,246.30 / 828.65
271.58
44.34
Torrent Pharmaceuticals Ltd.
2,764.75
1.55%
46,785.85
3,040.00 / 2,232.00
285.02
45.66
Biocon Ltd.
386.00
-0.76%
46,343.16
487.70 / 326.35
63.53
62.59
Gland Pharma Ltd.
2,787.05
-3.30%
45,681.07
2,982.00 / 1,701.00
222.52
59.11